Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Receptors, N-Methyl-D-Aspartate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Muscarinic < Receptors, N-Methyl-D-Aspartate < Receptors, Nerve Growth Factor  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000183 (2000) L V Metman ; S. Konitsiotis ; T N ChasePathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what.
000512 (2001) P. Del Dotto [Italie] ; N. Pavese ; G. Gambaccini ; S. Bernardini ; L V Metman ; T N Chase ; U. BonuccelliIntravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.
000784 (2002) Joanne E. Nash [Royaume-Uni] ; Jonathan M. BrotchieCharacterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
000B15 (2003) Juha-Matti Savola [Finlande] ; Michael Hill ; Mia Engstrom ; Hannele Merivuori ; Siegfried Wurster ; Steven G. Mcguire ; Susan H. Fox ; Alan R. Crossman ; Jonathan M. BrotchieFipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
001421 (2006) Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di PaoloPrevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
001704 (2006) Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli ; Edna Schechtman ; Ala Miniowich ; Rosa Strugatsky ; Roberto Ceravolo ; Chiara Logi ; Carlo Rossi ; Colin Klein ; J Martin RabeyAssociation between amantadine and the onset of dementia in Parkinson's disease.
002538 (2009) Hiroshi Kataoka ; Josep Dalmau ; Toshiaki Taoka ; Satoshi UenoReduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis.
002742 (2009) Jee-Young Lee [Corée du Sud] ; Eun Kyung Lee ; Sung Sup Park ; Ji-Yeon Lim ; Hee Jin Kim ; Ji Sun Kim ; Beom S. JeonAssociation of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
002F03 (2011) Jee-Young Lee [Corée du Sud] ; Jinwhan Cho ; Eun-Kyung Lee ; Sung-Sup Park ; Beom S. JeonDifferential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
003038 (2010) Rubio-Agustí Ignacio ; Dalmau Josep [États-Unis] ; Sevilla Teresa ; Burgal María ; Eduardo Beltrán ; Luís BatallerIsolated hemidystonia associated with NMDA receptor antibodies
003787 (2012) Paolo Calabresi [Italie] ; Massimiliano Di Filippo [Italie] ; Antongiulio Gallina [Italie] ; Yingfei Wang [États-Unis] ; Jeannette N. Stankowski [États-Unis] ; Barbara Picconi [Italie] ; Valina L. Dawson [États-Unis] ; Ted M. Dawson [États-Unis]New Synaptic and Molecular Targets for Neuroprotection in Parkinson’s Disease
003922 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. FoxNovel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
003A15 (2013) José Fidel Baizabal-Carvallo [États-Unis] ; Amber Stocco ; Eyal Muscal ; Joseph Jankovic [États-Unis]The spectrum of movement disorders in children with anti-NMDA receptor encephalitis.
003A48 (2013) Uriel Heresco-Levy [Israël] ; Shai Shoham ; Daniel C. JavittGlycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis.
003D18 (2014) Yael Hacohen [Royaume-Uni] ; Kumaran Deiva ; Phillipa Pettingill ; Patrick Waters ; Ata Siddiqui ; Pascale Chretien ; Esse Menson ; Jean-Pierre Lin ; Marc Tardieu ; Angela Vincent ; Ming J. LimN-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse.
003D47 (2014) Shekeeb S. Mohammad [Australie] ; Kate Sinclair ; Sekhar Pillai ; Vera Merheb ; Tim D. Aumann ; Deepak Gill ; Russell C. Dale ; Fabienne BrilotHerpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor.
003E98 (2014) Maarten J. Titulaer [Pays-Bas] ; Frank Leypoldt ; Josep DalmauAntibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.
004845 (1994) M B YoudimParkinson's disease and milacemide.
004926 (1994) J L Montastruc ; N. Fabre ; O. Rascol ; J M Senard ; O. BlinN-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
004982 (1993) M E Giuffra [États-Unis] ; V H Sethy ; T L Davis ; M M Mouradian ; T N ChaseMilacemide therapy for Parkinson's disease.
004A96 (1996) K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J T Greenamyre ; C. Dunn ; I. ShoulsonA controlled trial of remacemide hydrochloride in Huntington's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Receptors, N-Methyl-D-Aspartate" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Receptors, N-Methyl-D-Aspartate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Receptors, N-Methyl-D-Aspartate
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024